A. Tabernero et al., Effects of chronic and acute aminoguanidine treatment on tail artery vasomotion in ageing rats, BR J PHARM, 131(6), 2000, pp. 1227-1235
1 This study was designed to evaluate the effects of aminoguanidine, a sele
ctive inhibitor of the inducible isoform of nitric oxide synthase (iNOS), o
n the reactivity and intracellular calcium ([Ca2+](i)) mobilization induced
by noradrenaline in the perfused tail artery from aged WAG/Rij rats. Globa
l mean internal diameter was 350 +/- 15 microns and wail thickness 161 +/-
3 microns. The influence of the endothelium on these responses was also ana
lysed. The intracellular dye fura-2 for [Ca2+](i) measurements was used.
2 Noradrenaline-induced vasoconstriction decreased progressively from 3 to
20 and 30 months. Removal of the endothelium attenuated vasoconstriction in
20 and 30 month-old rats (P<0.05) but not in young rats.
3 Chronic administration of aminoguanidine (50 mg kg(-1) day(-1), p.o.) to
WAG/Rij rats from 20 to 30 months enhanced (P < 0.01) the [Ca2+](i)-sensiti
vity of noradrenaline-induced vasoconstriction.
4 Aminoguanidine (300 muM) in vitro significantly shifted the concentration
-vasoconstriction curve to noradrenaline to the left (P < 0.01) in denuded
vessels from both 20 and 30 month-old rats. The acute inhibitory effect of
aminoguanidine was also observed after chronic aminoguanidine treatment. Am
inoguanidine failed to modify vasoconstriction in the presence of the endot
helium.
5 Acute aminoguanidine (300 <mu>M) treatment did not modify vasoconstrictio
n induced by noradrenaline in young rats.
6 Quantification of iNOS mRNA expression in tail arteries from 3 and 20 mon
th-old WAG/Rij rats showed that expression was enhanced (x 2.1, P < 0.01) w
ith age.
7 These results suggest that an inflammatory process develops in the media
of the rat tail artery with age and that the subsequent increase in non-end
othelial iNOS activity attenuates noradrenaline-induced vasoconstriction.